Conduction Heterogeneity: Impact of Underlying Heart Disease and Atrial Fibrillation
- PMID: 33357582
- DOI: 10.1016/j.jacep.2020.09.030
Conduction Heterogeneity: Impact of Underlying Heart Disease and Atrial Fibrillation
Abstract
Objectives: The goal of this study is to investigate the impact of various underlying heart diseases (UHDs) and prior atrial fibrillation (AF) episodes on conduction heterogeneity.
Background: It is unknown whether intra-atrial conduction during sinus rhythm differs between various UHD or is influenced by AF episodes.
Methods: Epicardial sinus rhythm mapping of the right atrium, Bachmann's bundle (BB), left atrium and pulmonary vein area was performed in 447 participants (median age: 67 [interquartile range (IQR): 59 to 73] years) with or without AF undergoing cardiac surgery for ischemic heart disease, (ischemic and) valvular heart disease, or congenital heart disease. Conduction times (CTs) were defined as Δ local activation time between 2 adjacent electrodes and used to assess frequency (CTs ≥ 4 ms) and magnitude of conduction disorders (in increments of 10 ms).
Results: When comparing the 3 types of UHD, there were no differences in frequencies and magnitude of CTs at all locations (p ≥ 0.017 and p ≥ 0.005, respectively). Prior AF episodes were associated with conduction slowing throughout both atria (14.9% [IQR: 11.8 to 17.0] vs. 12.8% [IQR: 10.9 to 14.6]; p < 0.001). At BB, CTs with magnitudes ≥30 ms were more common in patients with AF (n = 56.2% vs. n = 36.0%; p < 0.004).
Conclusions: UHD has no impact on the frequency and severity of conduction disorders. AF episodes are associated with more conduction disorders throughout both atria and with more severe conduction disorders at BB. The next step will be to determine the relevance of these conduction disorders for AF development and maintenance.
Keywords: atrial fibrillation; cardiac surgery; conduction disorders; heart disease; sinus rhythm.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Author Disclosures Dr. de Groot is supported by funding grants from CVON-AFFIP (914728), NWO-Vidi (91717339), Biosense Webster USA (ICD 783454), and Medical Delta. This research (IIS-331 Phase 2) was conducted with financial support from the Investigator-Initiated Study Program of Biosense Webster, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
Conduction Slowing: Association or Causation in Atrial Fibrillation.JACC Clin Electrophysiol. 2020 Dec;6(14):1855-1857. doi: 10.1016/j.jacep.2020.10.010. JACC Clin Electrophysiol. 2020. PMID: 33357583 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials